The potential of aldehyde dehydrogenase 2 as a therapeutic target in cardiovascular disease

Thomas Münzel, Andreas Daiber
  • Expert Opinion on Therapeutic Targets, February 2018, Taylor & Francis
  • DOI: 10.1080/14728222.2018.1439922
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
Read Publication

http://dx.doi.org/10.1080/14728222.2018.1439922

The following have contributed to this page: Professor Thomas Munzel